Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.875 USD | -1.50% | +2.23% | -8.61% |
25/06 | Oppenheimer Initiates Coverage on Adverum Biotechnologies With Outperform Rating, $25 Price Target | MT |
11/06 | Adverum Biotechnologies, Inc. Announces Executive Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.61% | 145M | |
+16.02% | 122B | |
+18.87% | 113B | |
+18.95% | 26.49B | |
-23.38% | 19.4B | |
-19.03% | 16.24B | |
-20.04% | 15.4B | |
-46.14% | 15.15B | |
+65.37% | 14.93B | |
+5.24% | 13.52B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Transcript : Adverum Biotechnologies, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-10-2019 08